Members of the G protein receptor kinase (GRK) family that regulates receptor desensitization and members of the nuclear transcription factors family NFκB have been recently and convincingly demonstrated to interact, although the effects on transcription and gene expression have not yet been described. Using overexpression, knockdown (small interfering RNA) and mutagenesis experiments, we demonstrate that GRK5 couples to and stabilizes the NFκB inhibitor IκBα, and inhibits NFκB activity. Studies with minigenes suggest that the N-terminal Regulation of G protein Signaling (RGS) homology (RH) domain confers GRK5 such ability. GRK5-RH domain overexpression affects NFκB dependent phenotypes, such as apoptosis protection, cytokine production and inflammation and tissue regeneration. Our results reveal a novel, unexpected role of GRK5 in NFκB transcription activity regulation that represents a possible target for diagnostic and therapeutics.
Members of the G protein receptor kinase (GRK) family that regulates receptor desensitization and members of the nuclear transcription factors family NFκB have been recently and convincingly demonstrated to interact, although the effects on transcription and gene expression have not yet been described. Using overexpression, knockdown (small interfering RNA) and mutagenesis experiments, we demonstrate that GRK5 couples to and stabilizes the NFκB inhibitor IκBα, and inhibits NFκB activity. Studies with minigenes suggest that the N-terminal Regulation of G protein Signaling (RGS) homology (RH) domain confers GRK5 such ability. GRK5-RH domain overexpression affects NFκB dependent phenotypes, such as apoptosis protection, cytokine production and inflammation and tissue regeneration. Our results reveal a novel, unexpected role of GRK5 in NFκB transcription activity regulation that represents a possible target for diagnostic and therapeutics.
INTRODUCTION
G protein coupled receptor (GPCR) kinases, GRKs, constitute a large family of serine/threonine protein kinases that regulates GPCRs signalling [1] [2] [3] . GRKs phosphorilate agonist occupied GPCRs enhancing receptor affinity for β-arrestin 1 and 2 which suppress further inactivation between receptor and G proteins 4 , initiate clathrin-mediated endocytosis of phosphorylated receptors and can act as scaffolds to promote G protein independent intracellular signalling pathways 2, [5] [6] [7] . The GRK family consists of seven isoforms that share structural and functional similarities 8 . A central catalytic domain is flanked by an amino terminus domain that includes a region of homology to regulators of G protein signalling (RH) proteins and a carboxy terminal domain of variable length 9, 10 . GRKs kinase domain is relatively well conserved among the different subfamilies (~ 45% sequence identity), whereas N-terminal-RH domains display weak homology (~ 27%) and Ctermini have little or no sequence homology. GRKs have different tissue distribution, subcellular localization and kinase activity regulation 11, 12 . Since GRKs modulate receptor signalling, by inducing desensitization, their cellular localization is mostly believed at the plasma membrane, although GRKs shuttle within the cell 2 . Recently, Johnson et al. demonstrated that GRK4, 5 and 6, but not other GRKs, can localize in the nucleus, probably through a functional nuclear localization sequence (NLS) 11 . This evidence suggests a nuclear effect for the GRK4-6 subfamily and potentially novel roles for the GRKs in cellular function, beside receptor desensitization.
NFκB is an ubiquitously expressed and highly regulated dimeric transcription factor 3 . It plays a central role in regulating the expression of genes responsible for innate and adaptative immunity, stress responses, apoptosis, cell proliferation and differentiation [13] [14] [15] [16] [17] [18] . Its regulation is tightly associated to its subcellular localization, as it is controlled by the inhibitory proteins IκBs, mostly
IκBα. The NFκB/IκBα complex sits out the nucleus. Extracellular stimuli, such as tumor necrosis factor α (TNFα) or lipopolisaccharide (LPS), lead to the activation of the IκB kinase (IKK), which phosphorylates IκBα causing its subsequent degradation by the proteasome 19 . NFκB is therefore free to shuttle into the nucleus and to bind specific sequences in the promoter or enhancer regions of target genes 15 . This paradigm has been challenged by some recent observation that include in the picture a larger number of partners for the NFκB/IκBα complex. It has been described that NFκB/IκBα is actively exported from the nucleus by means of a nuclear transporter which reads a consensus nuclear exporting sequence (NES) on the N-terminus of IκBα, suggesting that the NFκB/IκBα shuttle continuously between the cytosol and the nucleus 1, 3 . A further interaction has been described between NFκB/IκBα and βarrestin 2, which causes accumulation within cytosol and blockade of NFκB transcriptional activity 20, 21 . All together these novel findings propose mechanisms of regulation of NFκB activity based on macrocomplexes formation and subcellular localization. In several cell types, NFκB drives VEGF, bFGF, IL-8 and other cytokines expression 22 . In the endothelium, cytokine production sustains a pivotal role in tissues regeneration, by providing the start to neoangiogenesis and therefore blood and nutrient support. Failure to NFκB activation associates with impaired cytokine production and angiogenesis in response to ischemia and wound healing 23, 24 .
On the basis of the flock of pre-existing observations outlined above, we hypothesized that GRK5
regulates NFκB transcription activity. We tested our hypothesis in vitro in endothelial cells and in vivo in the ischemic hindlimb and in the wound healing processes of the skin in the rat, to study the effects on post ischemia angiogenic responses.
RESULTS

GRK5 directly interacts with IκBα
To identify the role of GRK5 on NFκB signalling regulation in endothelium, we evaluated its ability to interact with IκBα, since it is the main and most studied regulator of NFκB activity 25 . In bovine aorta endothelial cell (BAEC) extracts, GRK5 is detected in immunoprecipitates of both IκBα and NFκB, suggesting that GRK5 can interact with IκBα/NFκB complex (Fig. 1A) . In resting cells IκBα is notoriously linked to NFκB; to rule out the possibility that the IκBα-GRK5 interaction is mediated by NFκB, we explored the ability of GRK5 to bind IκBα directly. To this aim, we used purified GRK5, GRK2, MEK-I and IκBα proteins for a binding assay; MEK I was chosen among the available purified kinases because it is structurally distant from the GRKs. As to GRK2, we analyzed its ability to interact with IκBα, since both GRK2 and GRK5 are considered prototypes of different GRK's subfamilies for important structural dissimilarities in the carboxyl terminus. Both GRK5 and GRK2 co-immunoprecipitate with IκBα (Fig 1B) , while MEK-I doesn't interact, indicating specific affinity between GRKs and IκBα. Further confirmation of the direct interaction was obtained in an overlay assay ( Supplementary Fig. S1 ) showing that GRK5 interacts with IκBα with a 5-time larger affinity than GRK2 (GRK2: 0.89 ± 0.09; GRK5: 4.78 ± 0.7 densitometric units;
P<0.05, ANOVA). This result suggests that the region of interaction between GRKs and IκBα lies either in the NT region, that comprises the RH domain, or in the catalytic domain, since they both are partially maintained between GRK2 and 5.
GRK5 and IκBα localize in the nucleus
The next question is whether the effects of such an interaction results in a phosphorylative event on
IκBα. Both purified GRK2 and GRK5 are able to phosphorylate IκBα in vitro, but GRK5 phosphorylation is 2.5 times greater than GRK2's ( Supplementary Fig. S2 ). The biological relevance of the phosphorylation of IκBα by GRK5 cannot be anticipated by experiments with purified proteins, and can only be explored in whole cell setups. Therefore, given the afore mentioned ability of GRK5 to translocate into the nucleus 11 , we evaluated GRK5 nuclear localization by western blot, in BAEC overexpressing the wild type (WT) or the kinase-dead mutant of GRK5 (K215R). GRK5-WT and GRK5-K215R are both found in appreciable amounts in the nucleus (Fig 1C) . Of note, both mutants cause an increase in the nuclear accumulation of IκBα and NFκB (Fig. 1C) . This suggests that the catalytic activity of GRK5 is not required to produce such nuclear accumulation of IκBα. The interaction appears to be ubiquitous, since also in human HEK293 cells, GRK5-WT overexpression increases IκBα levels. In this cell type, for which there is available a GRK5 siRNA 26 , GRK5 knockdown leads to reduction of the cellular levels of IκBα (Fig. 1D) . Therefore, the physical interaction of GRK5 and IκBα is needed for IκBα nuclear accumulation, independently from the kinase activity of GRK5.
GRK5 modulates NFκB activation
To explore the effects of GRK5 and IκBα interaction on NFκB activity regulation we performed a luciferase assay. GRK5-WT and GRK5-K215R overexpression in BAEC significantly inhibits NFκB transcription activity while GRK2 overexpression has no significant effect (Fig. 1E ). GRK5-WT overexpression causes NFκB transcription inhibition also in HEK293 cells, where GRK5
knockdown by siRNA increases NFκB activity (Fig. 1F ). Since the catalytic integrity of GRK5 is not needed for the effects on NFκB activity in cells, the physical interaction of IκBα and GRK5 represents the relevant mechanism of regulation.
RH is the interacting domain of GRK5 with IκBα
In order to map the IκBα binding region on GRK5, we created myc/histidine-tagged, truncated mutants of GRK5 including GRK5-WT (1-590 aa) GRK5-NT (1-171 aa), GRK5-RH (51-171 aa) and GRK5-CT (172-590 aa) ( Supplementary Fig. S3 and Fig. S4 ). Transient overexpression in BAEC of GRK5-WT, -NT and -RH, but not -CT, were all able to co-immunoprecipitate IκBα  in cells ( Fig. 2A) . These data point to the RH domain as the IκBα interacting domain of GRK5.
Indeed, the overexpression of GRK5-RH decreases the co-immunoprecipitation of IκBα with GRK5 ( Fig. 2B ) and therefore competes with endogenous GRK5 in the binding to IκBα. Hence, we conclude that GRK5-RH contains the interacting domain of GRK5 with IκBα.
We examined whether GRK5 domains were able to modulate IκBα levels by western blot. GRK5- 
GRK5-RH negatively regulates NFκB activity
To evaluate the effect of GRK5 single domains on the regulation of LPS-induced NFκB activity we performed a luciferase assay. The overexpression of GRK5-WT, -NT and -RH, but not -CT, significantly inhibits NFκB transcription of a reporter gene both in resting cells and after LPS stimulation (1μg/ml, 4 hours) (Fig. 2C ). To further confirm such effect we evaluated NFκB transcription activity by EMSA. GRK5-WT, -NT and -RH, but not -CT, overexpression cause a significant inhibition of LPS-induced NFκB DNA binding (Fig. 2D ).
GRK5-RH inhibits TNFα transcription
The biological consequences of this novel mechanism of regulation on NFκB were therefore investigated. It is well known that NFκB regulates the expression of many cytokines, including TNFα 17,24,27 . Since we demonstrated that GRK5-RH inhibits NFκB activation, we explored the ability of GRK5-RH to regulate cytokines expression, in particular TNFα, by means of northern blot. GRK5-WT, -NT and -RH, but not -CT, inhibit TNFα mRNA expression induced by LPS stimulation (Fig. 2E ).
GRK5-RH increases apoptosis
Biological implications can be also observed on phenotypes other than cytokine production. Indeed, 
GRK5-RH inhibits ECs migration and vascular tube formation.
We determined other proangiogenic phenotypes of BAEC that are affected by NFκB. In particular,
we evaluated the effects of GRK5-RH on migration of BAECs using a cell monolayer-wounding assay. In presence of Foetal Bovine Serum (FBS) 5%, BAECs display a greater capacity over unstimulated cells to migrate into the wounded area. GRK5-RH transfection inhibits FBS induced BAECs migration ( Fig. 3C and Supplementary Fig. S8 ). NFκB promotes endothelial tube formation on extracellular matrix which in vitro correspond to capillary network formation in vivo 32 . GRK5-RH affects this ability as well, by inhibiting vascular network formation on Matrigel matrix (Fig.   3D ). Our in vitro results build up to the notion that GRK5-RH negatively regulates the proangiogenic responses of BAECs.
AdGRK5-NT inhibits regenerative responses in vivo
To extend these observation to the in vivo setup, regenerative responses were obtained in rats, by chronic ischemia and wound healing. Chronic ischemia in the rat can be induced by femoral artery removal. We combined this technique with the vascular gene transfer, achieved by means of intrafemoral artery infusion of adenoviruses encoding for GRK5-NT (Ad-GRK5-NT, a kind gift from dr Walter Koch, Thomas Jefferson University) or a control (Ad-Empty). Acute ischemia causes an inflammatory response which causes the formation of new vessels and restoration of blood supply to the ischemic zone. By live digital angiography and TIMI score 33 , blood flow is partially restored after 14 days through the AdEmpty ischemic hindlimb (Fig 4A) . In Ad-GRK5-NT animals, this adaptative response is greatly impaired with a longer time to ischemic hindlimb perfusion (Fig. 4A ).
Validation of this result comes from dyed beads recovery from the rat limb muscles, after intraaortic infusion of dyed agarose beads (Fig. 4B ). This impaired response is paralleled by lower NFκB-dependent TNFα expression in the ischemic muscle of the Ad-GRK5-NT treated hindlimb (Fig. 4C) . Also, in vivo, NFκB activation sustains wound healing by chemokine production such as MCP1 and monocyte and neutrophils infiltration 34 . We treated blade imposed skin wounds with AdGRK5-NT and observed a longer time for skin healing ( Fig 4D) compared to AdEmtpy. This impaired response associates with a reduction of monocyte/neutrophil infiltrate ( Fig 4E) and lower expression of the chemokine MCP1 (Fig. 4F) .
DISCUSSION
To date, GRKs are known as protein kinases that specifically phophorylate and regulate activated
GPCRs, but recent findings unveiled that GRKs are also involved in several interactions with non receptor proteins (PI3K, AKT, MEK), suggesting new cellular functions for these kinases 20, [35] [36] [37] .
The present study identifies and characterizes a previously unknown interaction of GRK5 and IκBα leading to IκBα accumulation in the cell and NFκB activity inhibition.
Paramerswaran et al. demonstrated that GRKs RH domain binds p105, a NFκB precursor, and this binding was stronger for GRK5 than for GRK2 or GRK6 38 . Our results are in agreement with this finding and expand it to a greater extension since they clarify that IκBα is the partner of GRK5. We also demonstrated that both GRK5 and GRK2 interact with IκBα but GRK2 interaction is weaker than GRK5's, and indeed GRK2 has no effects on NFκB activity. This result is probably due to the weak homology of GRKs in the NT domain that, in presence of elevated amounts, makes GRK2 able to perform the same protein-protein interaction of GRK5. This homology can also explain the result of the Alliance for cell signalling that using a yeast two hybrid screening showed an interaction between GRK2 and NFκB (http://www.signalinggateway.org/data/Y2H/cgibin/y2h.cgi).
By cloning truncated forms of GRK5 we identify RH as the GRK5 domain involved in IκBα binding. Indeed, GRK5-RH overexpression causes IκBα nuclear accumulation and significantly decreases NFκB activation and DNA binding, also in presence of LPS stimulation.
Altogether our and previous results point to a protein-protein interaction as the regulatory mechanism for NFκB activity. Indeed, β-arrestin 2 has been described as a possible inhibitor of NFκB activity 4, 19, 39 , since the direct interaction of β-arrestin 2 with IκBα protein stabilizes IκBα levels 39 . β-arrestin 2 is mostly found in the cytosol, and this explains the finding of Gao et al.
showing that β-arrestin 2 overexpression decreased NFκB nuclear translocation, and blocks the IκBα/NFκB complex in the cytosol 20 . The results of our study differ from this previous report as we demonstrated that GRK5 enters the nucleus and stabilizes the IκBα/NFκB complex. These results suggest that GRK5 and βarrestin 2 regulate IκBα turnover by different mechanisms in different subcellular compartments. Our results therefore add to the notion that other partners participate to the regulation of NFκB activity through aggregation in macrocomplexes. Our data point to the nuclear localization of IκBα/NFκB complex. This is a much debated issue, since there is not a consensus on the ability of the complex to enter the nucleus. Recently, it has been proposed a dynamic model of the IκBα/NFκB complex localization. According to this model, the complex diffuses passively throughout the cell, but it is actively exported from the nucleus through a NES present on the carboxy terminal domain of IκBα, recognized by the nuclear transporter CRM-1 40 .
Our results fits to this model: we found that GRK5-RH binds to IκBα and prevents the export from the nucleus, possibly by masking the NES on IκBα to CRM-1, thus leading to nuclear accumulation of the IκBα/NFκB complex.
It is interesting to underscore that the kinase capability of GRK5 is not necessary to inhibit NFκB trascption activity, although it does phosphorylate in vitro IκBα. Indeed, the kinase dead GRK5 mutant was as effective as GRK5-WT to inhibit NFκB activity. The biological significance of GRK5 phosphorylation of IκBα remains unchartered. , chronic inflammation 22, 45 . Therefore, interventions aimed at limiting NFκB activation could be useful in clinical settings. For these reasons, we explored the eventual effects of our in vitro results in more complex models. In rats, NFκB inhibition results in impairment of regenerative responses. In the ischemic hindlimb, indeed, using an adenoviral mediated gene transfer of the RHencoding GRK5-NT minigene, we observed an impairment of the expected regenerative response.
Indeed, NFκB dependent transcription of TNFα is impaired 48 h after ischemia in the muscle of AdGRK5-NT treated animals. In the same limb, after 14 days we recorded a delay of blood flow recover. These data pair the results of the AdGRK5-NT-treated skin wounds. Also in this model, after 48 h from procedure, we observed an impairment in the production of MCP-1, a NFκB dependent chemokine, and a delay in the wound healing of the AdGRK5-NT treated rats. Our in vivo and in vitro data are well in agreement to show the negative effect of GRK5-NT on NFκB. On this note, it is interesting to observe that in hypertension, a condition associated with increased vascular levels of GRK5 48 , there is an impairment in neoangiogenesis in response to chronic ischemia 33 . Our data open an unchartered territory of exploration for the eventual role of GRK5 in the regulation of NFκB dependent phenotypes in vivo.
Given the widespread distribution of GRK5 within the immunological system, it is possible to predict a role of GRK5 beyond angiogenesis and tissue repair. Indeed, in animals with targeted deletion of GRKs, the progression of various acute and chronic inflammatory disorders, including autoimmunity and allergy, is profoundly affected 49 . In a future prospective GRK5-RH induced inhibition of NFκB transcription activity, independently from GPCRs desensitization, may be of physiological and pharmacological relevance in the context of those conditions which recognize an enhanced NFκB as the mechanism of disease.
EXPERIMENTAL PROCEDURES Cell culture
Endothelial cells from bovine aorta (BAEC) and HEK293 cells were cultured in Dulbecco's minimal essential medium (DMEM) supplemented with 10% foetal bovine serum (FBS) at 37°C in 95% air-5%CO 2.
GRK5 gene silencing
The siRNA sequence against human GRK5 and the gene silencing procedure have been described previously 50 .
Plasmid constructs, WesternBlot, nuclear extracts preparation and Immunoprecipitation.
Methods are extensively described in the data supplement
Apoptosis analysis
Extracts from cells in basal condition and with overexpression of GRK5-RH were lysed in RIPA/SDS (see data supplement) buffer and analyzed by western blot using anti-cleaved caspase 3 antibody (Cell signalling). Equal amount of proteins were normalized by actin.
In some experiments the detection of apoptosis was analyzed by Annexin-V-labeling using Annexin-V-FLUOS Staining kit (Roche) according to the manufacturer's instruction.
Luciferase assay
BAEC and HEK293 were transfected with plasmid expression vectors coding for a κB-luciferase reporter and β-galactosidase and GRK5 constructs as indicated above. Transient transfection was performed using the Lipofectamine 2000 (Invitrogen) according to manufacturer's instruction.
Twenty four hours after transfection, cells were serum starved overnight and stimulated with LPS (1μg/ml) for 4 hours. Lysates were analysed using the luciferase assay system with reporter lysis buffer from Promega and measured in a β-counter. Relative luciferase activity was normalized against the co-expressed β-galactosidase activity to overcome variations in transfection efficiency between samples.
Immunofluorescence
Cells were grown in chamber slides (Nunc, LabTek) and transfected as indicated above. Twentyfour hours after transfection, cells were fixed with -20°C cold methanol and permeabilized with 0.01% Triton X-100 in PBS. Primary antibodies incubation with anti-GRK5 raised against the amino-terminus region (Santacruz), anti-GRK5 raised against the carboxy-terminus region (Santacruz) and anti-IκBα (Santacruz) at a 1:100 diluition were performed at room temperature for one hour. Fluorescent labelled secondary antibodies were incubated at room temperature for one hour. Images were taken using an Eclipse E1000 Fluorescence Microscope (Nikon) and acquired using Sigma Scan Pro software (Jandel). Images were optimised for contrast in Adobe Photoshop, but no further manipulations were made.
Elettrophoretic mobility shift assay (EMSA)
EMSA was performed using nuclear extracts. Double stranded NFκB oligonucleotide (5' AGTTGAGGGGACTTTCCCAGGC 3') was end-labeled using [γ-32 P] ATP (GE Healthcare) and T4 polynucleotide kinase (Roche). Samples were subject to electrophoresis in 8% non denaturing polyacrilamide gels with 0.5 % TBE buffer. Digitalized gels autoradiographies were then quantified (Image Quant).
Northern blot
BAEC overexpressing GRK5 single domains were serum starved overnight and stimulated with LPS (1ug/ml) for four hours. Total RNA was isolated as described. 20 ug of total RNA was electrophoresed and transferred on nylon membrane according to standard procedures.
Hybridization was carried out using Quick Hyb solution (Stratagene). TNFα 32 P-labelled probe sequence was 5' TGCCCTTCCACCCCCTTGTTCCTCACCCACACCAT 3' (aa 436-470).
Transcript levels were quantified by autoradiography and densitometric analysis was performed using ImageQuant version 5.2. Equal amount loading of RNA was verified by 28S RNA visualization after ethidium bromide staining under UV. In some experiments total RNA was extracted from hindlimbs of GRK5-NT and control rats and TNFα expression was evaluated as described above. 
Migration and Matrigel Assays
Cellular migration and vascular tube formation were performed as previously described 51 .
Extended details are provided in the online data supplement.
In vivo Study Design
To perform gene transfer in vivo, we used and adenovirus encoding for the NT of GRK5 (AdGRK5-NT, a kind gift of Walter J. Koch, Jefferson University) and a non codifying adenovirus (AdEmpty).
Animals and Surgical Procedures
Ischemic hindlimbs were generated as described previously 33 . Extended details are provided in the online data supplement.
Skin wound healing
We studied 2 groups of healthy WKY rats: AdGRK5NT (n=10) and AdEmpty (n=8) treated.
Animals were anesthetized as previously described. After chemical hair removal (Nair, CarterWallace, New York, NY) the animals' backs were wiped with 30% isopropyl alcohol. Fullthickness skin wounds (10 mm diameter, 2 mm apart) were made by excising the dorsal skin and panniculus carnosus and the wound was left unrepaired. This standard technique was used in all procedures to ensure that the wounds were created with the same depth.
The wounds were allowed to dry in order to form a scar after the application of pluronic gel (200μl) containing AD-GRK5NT or AD-Empty (10 9 pfu). In a subset of rats, animals were euthanized, and wounds were harvested 3 days after wounding. An area of 15 mm in diameter which includes the complete epithelial margins was excised at each time point. A similar amount of skin from the backs of three non-wounded animals was used as a control. Wound tissues were fixed in 10% neutral buffered formalin for paraffin embedding for histology and immunohistochemistry. To monitor the wound-healing process we took digital pictures of the scars at 1, 2, 3, 5, and 7 days after incision.
Histology and Immunocytochemistry
Paraffin embedded, sections were stained for hematoxylin and eosin. Five μm-thick sections were processed for the triple layered immunocytochemical PAP (peroxidase anti-peroxidase) method. A goat anti-rat MCP1 (Santa Cruz) diluted 1:250 antiserum was used to localise monocytemacrophage system cells: In order to reveal the primary antibody, a secondary donkey anti-goat (Calbiochem) antibody diluted 1:100 was used, followed by a goat PAP complex (Calbiochem, 1:100). The peroxidase was revealed in presence of 0,03% hydrogen peroxyde and of an electron donor, 2,5% diaminobenzidine, which becomes visible as a brown precipitate. For negative controls, the primary antiserum was omitted or normal goat serum was used instead of first layer.
Sections were then viewed with a Leitz Diaplan microscope provided with a Leica DC200 digital camera.
Statistical Analysis
All values are presented as mean ± SEM. Two In AdGRK5-NT treated wounds, Hematoxyilin/Eosin staining revealed a smaller amount of
